Small Molecule API Market To Exhibit Ravishing Growth By 2026

A Small
molecule Active Pharmaceutical Ingredient (API) is a low
molecular weight organic compound, which may help to control
biological process, with a size on the order of 1 nm. Most of the
small molecule can be administered orally and are most likely to be
absorbed by the body. Owing to its small size it has properties of
rapid diffusibility to reach at intracellular site of action.
Small Molecule
API Market – Dynamics
The small molecule
API market is witnessing rapid growth due to increasing number of
corporate agreements. For instance, BASF Pharma will sell its OMEGA 3
manufacturing facility in Norway to Marine Ingredients. The Highly
Potent Active Pharmaceutical Ingredients (HPAPI) is projected to
witness high growth rate, owing to easy access to the people for
medication in emerging economies. The rising prevalence of diseases
such as cancer, cardiovascular, and infectious diseases is expected
to propel demand for manufacturing of small molecule APIs. According
to the National Center for Biotechnology Information (NCBI) report,
in 2014, out of 570,341 deaths 29.4% were due to cancer and 27.1%
were due to cardiovascular disease. Increasing consumer awareness,
benefits of small molecule API, expiry of patents covering the
top-selling pharmaceuticals, and technological advancement in
manufacturing sector are expected to drive the market growth over the
forecast period. Increasing adoption of generic drugs has resulted
into affordable healthcare expenditure, which is expected to increase
production of small molecule API’s, in turn driving the global
small molecule API market growth. According to the Indian Brand
Equity Foundation (IBEF), in 2018, India is largest producer of
generic medicines, which supplies 50% of vaccines and 40% of drugs to
the U.S. and 25% of drugs to the U.K.
Small Molecule
API Market – Regional insights
North America held
the largest market share for small molecule API registering for
38.84% in 2017, due to high adoption rate of accelerated regulatory
review of innovative medicines. Asia Pacific excluding Japan (APEJ)
market is estimated to witness rapid growth in market, owing to high
adoption of over the counter (OTC) drugs by large patient population
coupled with growing healthcare and pharmaceutical industry and
strong research and development in API. According to IBEF, investment
in research and development by Indian pharmaceutical companies
increased (in term of sales) from 5.3% to 8.5% from 2012 to 2018.
Small Molecule
API Market – Competitive landscape
The major player
operating in global small molecule API market include ALLERGAN,
Aurobindo Pharma, Cambrex Corporation, Albemarle Corporation, D.r.
Reddy’s Laboratories Ltd. The other key players in market are
Johnson Matthey, Siegfried Holding AG, Pfizer, Sanofi S.A., Novartis
AG, Johnson & Johnson, Bristol-Myers Squibb, Bachem Holding AG,
Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline
PLC, GILEAD Science Inc., Albany Molecular Research Inc., Sun
Pharmaceuticals, AstraZeneca, Merck & Co, Inc., BASF SE, and
Teva Pharmaceuticals. In March 2012, the FDA approved Ilumya
(Tildrakizumab-asmn) developed by Sun Pharmaceuticals used for Plaque
Psoriasis.
Inquire Here
Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2423
Global Small
Molecule API - Market Taxonomy
On the basis
of API type, the global small molecule API market is segmented into:
Synthetic
Biological
On the basis
of application, the global small molecule API market is segmented
into:
Oncology
Neurology
Metabolic
Infectious
Cardiovascular
On the basis
of geography, the global small molecule API market is segmented into
North
America
Europe
Asia Pacific
Latin
America
Middle East
Africa
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment